(Q43666330)

English

Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.

scientific article published on 2 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Myron Christodoulides

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Holly E Humphries

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jeannette N Williams

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ramona Blackstone

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ho M Yuen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

John E Heckels

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

2 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

36-44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Impact of meningococcal C conjugate vaccine in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

The antimeningococcal vaccine VAMENGOC B-C induced poor serum and salivary antibody response in young Brazilian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococc

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Recombinant meningococcal PorA protein, expressed using a vector system with potential for human vaccination, induces a bactericidal immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Expression ofNeisseria meningitidisclass 1 porin as a fusion protein inEscherichia colli: the influence of liposomes and adjuvants on the production of a bactericidal immune reesponse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Point mutation in meningococcal por A gene associated with increased endemic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Lack of Immunity in University Students before an Outbreak of Serogroup C Meningococcal Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Relative Immunogenicity of PorA Subtypes in a Multivalent Neisseria meningitidis Vaccine Is Not Dependent on Presentation Form

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Naturally occurring insertional inactivation of theporAgene ofNeisseria meningitidisby integration of IS1301

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

based on heuristic

inferred from DOI database lookup

Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.056

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.07.056

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

release_4got4ascgjg2jfvczmw2holu5i

1 reference

https://api.fatcat.wiki/v0/release/4got4ascgjg2jfvczmw2holu5i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16105711%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43666330&oldid=2102391878"